Compositions and methods for vaccinating against HSV-2
US8840903B2 · kind B2 · utility
1Cited by
20References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 9, 2012 |
| Grant date | Sep 23, 2014 |
| Priority date | — |
| Expiry date | Aug 9, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2710/16634
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to therapeutic polynucleotide compositions and methods for systemic immune activation which are effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in mammals. The polynucleotide compositions are particularly effective for protecting mammals from herpes simplex virus (HSV), such as HSV gD2, VP11/12, and VP13/14 polypeptides.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.